Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain-like state using fMRI and brain wave analysis

Synapse

Volumn 65, Issue 7, 2011, Pages 668-676

  Takemura, Yoshinori ^a,b   Yamashita, Akira ^a   Horiuchi, Hiroshi ^a   Furuya, Masaharu ^a   Yanase, Makoto ^a   Niikura, Keiichi ^a   Imai, Satoshi ^a   Hatakeyama, Noboru ^b   Kinoshita, Hiroyuki ^c   Tsukiyama, Yoshi ^d   Senba, Emiko ^c   Matoba, Motohiro ^e   Kuzumaki, Naoko ^a   Yamazaki, Mitsuaki ^b   Suzuki, Tsutomu ^a   Narita, Minoru ^a,b  

^a HOSHI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d WAKAYAMA MEDICAL UNIVERSITY HOSPITAL   (Japan)

^e NATIONAL CANCER CENTER   (Japan)

Author keywords

Chronic pain; EEG; FMRI; Gabapentin; Neuropathic pain

Indexed keywords

GABAPENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD OXYGENATION; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HYPERALGESIA; MALE; MOUSE; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; SCIATIC NERVE; SLEEP DISORDER;

AMINES; ANALGESICS; ANIMALS; AXOTOMY; BRAIN; BRAIN MAPPING; BRAIN WAVES; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; MAGNETIC RESONANCE IMAGING; MAGNETOENCEPHALOGRAPHY; MALE; MICE; MICE, INBRED C57BL; NEURALGIA; PAIN MEASUREMENT; SCIATIC NERVE; SLEEP DISORDERS;

EID: 79954422841     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20898     Document Type: Article

References (62)

1. Atkinson JH, Ancoli-Israel S, Slater MA, Garfin SR, Gillin JC. 1988. Subjective sleep disturbance in chronic back pain. Clin J Pain 4: 225-232.
2. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P. 2006. EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13: 1153-1169.
3. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. 1998. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 280: 1831-1836.
4. Becerra LR, Breiter HC, Stojanovic M, Fishman S, Edwards A, Comite AR, Gonzalez RG, Borsook D. 1999. Human brain activation under controlled thermal stimulation and habituation to noxious heat: An fMRI study. Magn Reson Med 41: 1044-1057.
5. Beiche F, Brune K, Geisslinger G, Goppelt-Struebe M. 1998. Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm Res 47: 482-487.
6. Borsook D, Moulton EA, Schmidt KF, Becerra LR. 2007. Neuroimaging revolutionizes therapeutic approaches to chronic pain. Mol Pain 3: 25.
7. Chapman V, Suzuki R, Chamarette HL, Rygh LJ, Dickenson AH. 1998. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 75: 261-272.
8. Chizh BA, Scheede M, Schlutz H. 2000. Antinociception and (R, S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid antagonism by gabapentin in the rat spinal cord in vivo. Naunyn Schmiedebergs Arch Pharmacol 362: 197-200.
9. Coderre TJ, Kumar N, Lefebvre CD, Yu JS. 2007. A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. J Neurochem 100: 1289-1299.
10. Couceiro TC, Menezes TC, Valênça MM. 2009. Post-mastectomy pain syndrome: The magnitude of the problem. Rev Bras Anestesiol 59: 358-365.
11. Craig AD. 1996. An ascending general homeostatic afferent pathway originating in lamina I. Prog Brain Res 107: 225-242.
12. 2+ channel alpha2delta ligands: Novel modulators of neurotransmission. Trends Pharmacol Sci 28: 75-82.
13. Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G. 2000. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 91: 185-191.
14. Field MJ, Hughes J, Singh L. 2000. Further evidence for the role of the alpha(2)delta submit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 131: 282-286.
15. Fox A, Gentry C, Patel S, Kesingland A, Bevan S. 2003. Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin on a model of neuropathic pain in the rat and guinea-pig. Pain 105: 355-362.
16. Galer BS, Gianas A, Jensen MP. 2000a. Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47: 123-128.
17. Galer BS, Henderson J, Perander J, Jensen MP. 2000b. Course of symptoms and quality of life measurement in Complex Regional Pain Syndrome: A pilot survey. J Pain Symptom Manage 20: 286-292.
18. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. 1996. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 271: 5768-5776.
19. Goppelt-Struebe M, Beiche F. 1997. Cyxlooxygenase-2 in the spinal cord: Localization and regulation after a peripheral inflammatory stimulus. Adv Exp Med Biol 433: 213-216.
20. Governo RJ, Morris PG, Marsden CA, Chapman V. 2008. Gabapentin evoked changes I functional activity in nociceptive regions in the brain of the anaesthetized rat: An fMRI study. Br J Pharmacol 153: 1558-1567.
21. Han ZS, Zhang ET, Craig AD. 1998. Nociceptive and thermoreceptive lamina I neurons are anatomically distinct. Nat Neurosci 1: 218-225.
22. Haythornthwaite JA, Hegel MT, Kerns RD. 1991. Development of a sleep diary for chronic pain patients. J Pain Symptom Manage 6: 65-72.
23. Hazelrigg SR, Cetindag IB, Fullerton J. 2002. Acute and chronic pain syndromes after thoracic surgery. Surg Clin North Am 82: 849-865.
24. Hempenstall K, Nurmikko TJ, Jonhson RW, A'Hern RP, Rice AS. 2005. Anelgesic therapy in postherpetic neuralgia: 1 Quantitative systematic review. PLoS Med 2: e164.
25. Honey GD, Corlett PR, Absalom AR, Lee M, Pomarol-Clotet E, Murray GK, McKenna PJ, Bullmore ET, Menon DK, Fletcher PC. 2008. Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. J Neurosci 28: 6295-6303.
26. Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O'Keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW. 2000. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med 6: 521-528.
27. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, et al. 1997. The effect of novelanti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324: 153-160.
28. Hwang JH, Yaksh TL. 1997. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth 22: 249-256.
29. Iannetti GD, Zambreanu L, Wise RG, Buchanan TJ, Huggins JP, Smart TS, et al. 2005. Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc Natl Acad Sci USA 102: 18195-18200.
30. Ji RR, Woolf CJ. 2001. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 8: 1-10.
31. Jones AK, Brown WD, Friston KJ, Qi LY, Frackowiak RS. 1991. Cortical and subcortical localization of response to pain in man using positron emission tomography. Proc Biol Sci 244: 39-44.
32. Jones DL, Sorkin LS. 1998. Systemic gabapentin and S(+)-3-isobutyl-gamma-aminobutyric acid block secondary hyperalgesia. Brain Res 810: 93-99.
33. Joshi SK, Hernandez G, Mikusa JP, Zhu CZ, Zhong C, Salyers A, et al. 2006. Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity. Neuroscience 143: 587-596.
34. Jun JH, Yaksh TL. 1998. The effect of intrathecal gabapentin and 3-isobutyl gamma-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat. Anesth Analg 86: 348-354.
35. Karmakar MK, Ho AM. 2004. Postthoracotomy pain syndrome. Thorac Surg Clin 14: 345-352.
36. Koehler RP, Keenan RJ. 2006. Management of postthoracotomy pain: Acute and chronic. Thorac Surg Clin 16: 287-297.
37. Leslie RA, James MF. 2000. Pharmacological magnetic resonance imaging: A new application for functional MRI. Trends Pharmacol Sci 21: 314-318.
38. Ling B, Authier N, Balayssac D, Eschalier A, Coudore F. 2007. Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat. Pain 128: 225-234.
39. Lynch JJIII, Wade CL, Zhong CM, Mikusa JP, Honore P. 2004. Attention of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model. Pain 110: 56-63.
40. Melzack R. 1999. From the gate to the neuromatrix. Pain (Suppl) 6: S121-S126.
41. Moffitt PF, Kalucy EC, Kalucy RS, Baum FE, Cooke RD. 1991. Sleep difficulties, pain and other correlates. J Intern Med 230: 245-249.
42. Morin CM, Gibson D, Wade J. 1998. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain 14: 311-314.
43. Nicholson B, Verma S. Comorbidities in chronic neuropathic pain. Pain Med 5(Suppl 1): S9-S27.
44. O'Brien EM, Waxenberg LB, Atchison JW, Gremillion HA, Staud RM, McCrae CS, Robinson ME. 2010. Negative mood mediates the effect of poor sleep on pain among chronic pain patients. Clin J Pain 26: 310-319.
45. Pilowsky I, Crettenden I, Townley M. 1985. Sleep disturbance in pain clinic patients. Pain 23: 27-33.
46. Ramesh, Shukla NK, Bhatnagar S. 2009. Phantom breast syndrome. Indian J Palliat Care 15: 103-107.
47. Rice AS, Maton S. 2001. Gabapentin in postherpetic neuralgia: A randomized, double blind, placebo controlled study. Pain 94: 215-224.
48. Ro LS, Chang KH. 2005. Neuropathic pain: Mechanisms and treatments. Chang Gung Med J 28: 597-604.
49. Rorden C, Karnath HO. 2004. Using human brain lesions to infer function: A relic from a past era in the fMRI age? Nat Rev Neurosci 5: 813-819.
50. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. 1998. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 280: 1837-1842.
51. Shih YY, Chen YY, Chen CC, Chen JC, Chang C, Jaw FS. 2008. Whole-brain functional magnetic resonance imaging mapping of acute nociceptive responses induced by formalin in rats using atlas registration-based event-related analysis. J Neurosci Res 86: 1801-1811.
52. Shimoyama M, Shimoyama N, Hori Y. 2000. Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain 85: 405-414.
53. Stanfa LC, Singh L, Williams RG, Dickenson AH. 1997. Gabapentin, ineffective in normal rats, markedly reduces C-fiber evoked responses after inflammation. Neuroreport 8: 587-590.
54. Talbot JD, Marrett S, Evans AC, Meyer E, Bushnell MC, Duncan GH. 1991. Multiple representations of pain in human cerebral cortex. Science 251: 1355-1358.
55. Treede RD, Kenshalo DR, Gracely RH, Jones AK. 1999. The cortical representation of pain. Pain 79: 105-111.
56. Troels SJ, Nanna BF. 2009. Neuropathic pain treatment: A further step forward. Lancet 374: 1218-1219.
57. Vecht CJ, Van de Brand HJ, Wjer QJ. 1989. Post-axillary dissection pain in breast cancer due to a lesion of the intercostobrachial nerve. Pain 38: 171-176.
58. Wise RG, Rogers R, Painter D, Bantick S, Ploghaus A, Williams P, Rapeport G, Tracey I. 2002. Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil. Neuroimage 16: 999-1014.
59. Wise RG, Williams P, Tracey I. 2004. Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain. Neuropsychopharmacology 29: 626-635.
60. Xiao W, Boroujerdi A, Bennett GJ, Luo ZD. 2007. Chemotherapy-evoked painful peripheral neuropathy: Analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 144: 714-720.
61. Zgierska A, Brown RT, Zuelsdorff M, Brown D, Zhang Z, Fleming MF. 2007. Sleep and daytime sleepiness problems among patients with chronic noncancerous pain reciving long-term opioid therapy: A cross-sectional study. J Opioid Manag 3: 317-327.
62. Zhang RX, Lao L, Qiao JT, Malsnee K, Ruda MA. 2004. Endogenous and exogenous glucocorticoid suppresses up-regulation of preprodynorphin mRNA and hyperalgesia in rats with peripheral inflammation. Neurosci Lett 359: 85-88.